BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2001
View Archived Issues
ET antagonists may have therapeutic role in diabetic erectile dysfunction
Read More
Abarelix depot shows good results in phase III prostate cancer studies
Read More
Bayer's new PDE5 inhibitor improves ED over 12 weeks of therapy
Read More
MVAC improves life expectancy in bladder cancer when administered prior to cystectomy
Read More
Thalomid/Xeloda combination to be evaluated for treatment of colorectal cancer
Read More
Roche and Vernalis identify lead candidate for treatment of obesity
Read More
Health Canada approves Rapamune for immunosuppression following renal transplantation
Read More
Animal studies demonstrate penile erection-enhancing effects of systemic and intranasal PT-141
Read More
Celltech launches Metadate CD for ADHD in U.S.
Read More
Joint venture focused on treatment of pain established by CeNeS and Elan
Read More
Successful gene transfer obtained following repeated doses of aerosolized tgAAVCF in primates
Read More
ZymoGenetics and BioMimetic establish agreement for rhPDGF clinical development
Read More
Intratumoral RPR/INGN-201 not associated with biosafety concerns in phase II trial
Read More
HGS cleared to proceed with phase I trial of Albutropin for treatment of GH deficiency
Read More
Avigen receives FDA approval to begin second trial of Coagulin-B for hemophilia B
Read More
INGN-241: preclinical findings reported at American Society of Gene Therapy meeting
Read More
Lilly's Zyprexa approved for treatment of schizophrenia in Japan
Read More
Miravant to commence phase I trials of new topical PhotoPoint drug for plaque psoriasis
Read More
Use of radolmidine for preventing hypotension and shock
Read More
Salix reports results of second phase III trial of rifaximin
Read More
Antiapoptotic compounds from ARS act on Bax and cytochrome c
Read More
Bicyclic amino acids mimic effects of gabapentin, may be useful for neuropathological conditions
Read More
Immune Response's phase II trial of Remune fails to meet primary endpoint
Read More
GnRH antagonists useful for sex hormone-related disorders claimed by Neurocrine Biosciences
Read More
Antiasthmatic effects of YM-976 due mainly to antiinflammatory activity
Read More
Tricyclic HIV RT inhibitors prepared at DuPont
Read More
Three patents issued to Merck for new antibacterial DNA polymerase inhibitors
Read More